| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |